drugset / Trial / NCT00902564
Escitalopram in Patients With Generalized Anxiety Disorder
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effect of escitalopram after 8 weeks of treatment in patients with Generalized Anxiety Disorder (GAD), to evaluate proportion of patients who respond to escitalopram during the treatment period, and to evaluate safety of escitalopram.
Timeline
- Start
- 2009-03
- Primary completion
- 2009-12
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Escitalopram | Small molecule | 5 mg | Oral |
| Subject | Escitalopram | Small molecule | 20 mg | Oral |